GBS is known as a part of the intestinal and vaginal microbiota in 15 - 30% of healthy women; nonetheless, it has an extreme capacity to cause invasive infections. This bacterium is a significant cause of infections in infants, pregnant women, and adults with underlying diseases. This pathobiont, which grows in healthy individuals, has maintained its potential virulence during coevolution with humans. It is well established that this bacterium is one of the most life-threatening pathogens in neonates and the elderly. Moreover, it has been reported that one in every 10 newborn infants acquires GBS vertically while passing through the birth canal or soon afterward (
1,
2,
9,
10). In 1996, the Centers for Disease Control and Prevention (CDC) issued guidelines for the prevention of GBS before delivery, recommending screening for GBS colonization in prenatal women. Although previous studies reported that up to 50% of infants with GBS are born to carriers without clinical risk factors, the CDC guidelines were revised in 2002, and bacteriological screening became mandatory for all pregnant women at 35 - 37 weeks of gestation. Therefore, for improving public health, it is important to quickly identify and differentiate GBS strains (
11).
The GBS adherence and colonization, as complex multifactorial functions, guarantee the maintenance of this pathobiont in human ecosystems. Over the last two decades, molecular adherence mechanisms have been further studied in GBS, leading to a significant increase in our understanding of disease progression. The GBS adhesion factors may present new targets for the emergence of novel treatments and preventive actions to control and prevent invasive GBS infections in newborns and adult patients, as the frequency of vaginal-rectal colonization of GBS changes significantly across geographical regions, even in a single country. Data regarding the source of infection and relatedness of isolates can be beneficial for preventive strategies and selection of the best treatment (
12). In the current study, besides assessing the concomitant presence of central colonization genes through multiplex PCR assay, the amenability of BOX-PCR fingerprint technique was investigated to differentiate GBS isolates collected from urinary and placental samples of pregnant women, referred to one of the hospitals of Tehran, Iran.
Significant adhesions that mediate the colonization of GBS on host cells, including fibrinogen-binding proteins (Fbs A and B), laminin-binding protein (Lmb), and a recently identified fibronectin-binding protein (SfbA), were concomitantly studied in the GBS isolates using the multiplex PCR assay. The results revealed that all GBS isolates harbored the studied colonization genes. Therefore, colonization-related genes showed a similar distribution among isolates originating from two different types of clinical samples (urine and placenta). The positive rates of colonization genes, including
fbsA and
fbsB, were identical to those reported in previous studies, except for
lmb; this result is consistent with the finding that most human isolates contain
fbsA and
fbsB genes (
7,
13,
14). Additionally, previous studies have indicated the concomitant harboring of three or more than three colonization-related genes in the GBS isolates (
15,
16). However, the distribution rate of genes for surface-localized proteins, such as
fbsA and
fbsB, was different, while
lmb was found in all the isolates. Discrepancies in the distribution and abundance of colonization-related genes are probably related to regional differences; therefore, identification and survey of dominant colonization-associated genes in different geographical regions are suggested as an appropriate tool to design efficient vaccines for the prevention of GBS infections in pregnant women (
17).
The
sfbA gene was also harbored by all isolates in the current study. Similar studies have earlier reported that
sfbA gene is present in GBS and highly conserved (
4,
18). The present study is the first report of
sfbA gene identification among GBS isolates collected from pregnant women in Iran. The BOX primer sequence was used in a PCR assay to determine differences in the number and distribution of this bacterial repeat sequence in the genomes of clinical GBS isolates. Although among different molecular techniques for typing bacterial strains, pulse-field gel electrophoresis (PFGE) is known as the superior technique for bacteria, it is both labor-intensive and costly (
19). In contrast to PFGE, BOX-PCR is known as the most commonly applied method in biogeographic studies of bacterial isolates. Researchers have demonstrated that this technique is rapid, vastly discriminative, and reproducible (
8). Therefore, BOX-PCR was identified as a selective typing method for GBS isolates in this study.
According to the current findings, the most frequent genotypes were genotypes 2, 4, and 6 found in 23 (38.33%), 10 (16.66%), and 15 (25%) isolates, respectively. The subsequent genotypes, including genotypes 1, 3, and 5, were each found in 4 (6.66%) isolates. The isolation source in most GBS isolates (73.33%) was the placenta of patients, while the remaining isolates (26.66%) were obtained from the urinary samples. Except for genotype 3, other genotypes were found in isolates from both samples; this finding revealed that isolates from the placental and urinary samples were highly heterogeneous.
To the best of our knowledge, there are no publications in Iran or other countries on the molecular typing of GBS using BOX-PCR. Nevertheless, genotyping of GBS using other fingerprint techniques has been reported (
20,
21). Also, the effectiveness of BOX-PCR in determining genetic relatedness has been investigated for other bacterial species. For instance, the eligibility and reproducibility of BOX-PCR and ERIC-PCR were used as molecular typing tools for the genetic discrimination of
Enterococcus faecalis.
Besides, other researchers have reported the potential of BOX-PCR to differentiate
Proteus mirabilis strains from clinical
Pseudomonas aeruginosa isolates (
22-
25). In other studies from other countries, BOX-PCR and ERIC-PCR were introduced as powerful surveillance techniques for studying the genetic relatedness of
Leptospira,
Fusarium oxysporum, and
Salmonella enterica isolates from patients (
8,
26,
27). Samples included in this research were collected from a hospital in Tehran, Iran during the six-month period from January to July 2021. Thus, the results of this study may not be generalized to other areas. More investigations are required on samples collected from different regions of Iran and during various seasons.
5.1. Conclusions
Based on the results of the present study, four important colonization-related genes, including fbsA, fbsB, lmb, and sfbA, were concomitantly detected in all 60 GBS isolates. The BOX-PCR fingerprint technique could discriminate GBS isolates, collected from placental and urinary samples of pregnant women, into six different groups. Since the analysis of phenotypic features does not present a classification system, this DNA fingerprint technique can be a rapid and useful tool for identifying GBS isolates.